Skip to main content

Tweets

How would vagus nerve stimulation help Rheumatoid Arthritis?? #ACR19 @rheumnow Abst0930 https://t.co/NupaKJkXCL
Dr Irwin Lim @_connectedcare ( View Tweet )
6 years 9 months ago
The C-VIEW open-label study found a significant reduction in the AAU flare rate in axSpA pts with a history of recurrent AAU during the first 48 wks of Certolizumab. Pts also experienced significant improvement in axSpA disease activity #ACR19 @RheumNow

Dr. Antoni Chan @synovialjoints ( View Tweet )

6 years 9 months ago
@RheumNow #ACR19 ABS377 Stanford Univ retrosp stdy of pts w/ cardiac sarcoidosis supports use of TNFi in pts who failed cDMARs. Pts were able to reduce steroids dose w/no decline in LVEF in pts with preexisting CHF. larger, prospect studies needed

Olga Petryna @DrPetryna ( View Tweet )

6 years 9 months ago
This is the device they used for the vagus nerve stimulation #ACR19 @rheumnow Abst0930 https://t.co/XGKRjONTqf
Dr Irwin Lim @_connectedcare ( View Tweet )
6 years 9 months ago
2 papers looking at TNFi on radiographic progression in Ankylosing Spondylitis. TNF inhibitor treatment slowed radiologic progression when compared to other therapies but covariables such as smoking and NSAIDs need to be considered #ACR19 @RheumNow

Dr. Antoni Chan @synovialjoints ( View Tweet )

6 years 9 months ago
Filgotinib in RA (FINCH3); Another👍🏼 result for JAKi How will we choose which JAKi to use in an increasing crowded space? Any thoughts? #ACR19 @rheumnow Abst0927

Dr Irwin Lim @_connectedcare ( View Tweet )

6 years 9 months ago
@rheumnow #ACR2019 ABS857 Stdy of 21 SLE pts received allogenic mesench stem cells IV ⬇️ inflamm through upregulation of periph tolerogenic CD1c+ DC, esp in LN. UC-MSCs express FLT3L that binds to FLT3 on CD1c+DCs to promote proliferat&inhibit apoptosis of tolerogenic CD1c+DCs

Olga Petryna @DrPetryna ( View Tweet )

6 years 9 months ago
Over two years, there can be progression of facet joint ankylosis with most progression occurring in the thoracic spine. Whole spine low dose CT is a research tool to study progression of facet joint in radiographic axSpA patients. van Gaalen #ACR19 @rheumnow

Dr. Antoni Chan @synovialjoints ( View Tweet )

6 years 9 months ago
#acr19 @rheumnow abstr#0849 #ACRbest French database: Risk for CA in RA with biologics compared to traditional sDMARDS: n= 83,659 1. No ⬆️ risk solid malig 2. HR lymphoma 1.35. p value not sig 3. NO diff CA b/t biologic monoRx vs comb biologic + DMARD *nonmelanomatous skin CA
6 years 9 months ago
The discrepancy in diagnosis between rheumatologists and radiologists reflects the increasing insecurity of including only BME of SIJ as the major criterium for diagnosing axSpA. Structural changes are also important. Baraliakos #ACR19 @RheumNow #axialspondyloarthritis

Dr. Antoni Chan @synovialjoints ( View Tweet )

6 years 9 months ago
Listening to ⁦@AngusWorthing⁩ talk about what ⁦@ACRheum⁩'s advocacy efforts are doing for their members. #ACR19 @rheumnow https://t.co/aLYPuh0Clr
Dr. Paul Sufka @psufka ( View Tweet )
6 years 9 months ago
Semi-axial combined with standard semi-coronal scans in MRI protocols for sacroiliitis improved recognition of non-specific BME, which is in the posterior lower ilium in association with SIJ features, and in the anterior upper sacrum #ACR19 @RheumNow #axialspondyloarthritis

Dr. Antoni Chan @synovialjoints ( View Tweet )

6 years 9 months ago
There is a strong association between smoking and MRI-SIJ inflammation over time in axSpA patients with type of work and level of education level irrespective of other socio-economic factors, systemic inflammation and treatment. Nikiphorou #ACR19 @RheumNow

Dr. Antoni Chan @synovialjoints ( View Tweet )

6 years 9 months ago
Abstr#0848 @rheumnow #acr19 another study confirming that steroids dose correl to hospitalized infx: from Medicare database https://t.co/6SZqd0A8Xv
6 years 9 months ago
Abstr#0846 ⁦@RheumNow⁩ #acr19 #acrbest Eval of MACE and VTE of UPA based on phs 3 trials: 1. NO ⬆️risk MACE/VTE over 2 yrs compared to MTX, ADA 2. NO correl. w/lipid levels, dose of drug with MACE/VTE and UPA. * despite the safety seen, UPA’s label still include VTE risk https://t.co/unOBvoW8Ub
6 years 9 months ago
×